Does TOFACITINIB Cause Dermatitis? 98 Reports in FDA Database

Q: Does TOFACITINIB cause Dermatitis?

98 reports of Dermatitis have been filed with the FDA for TOFACITINIB, representing 0.1% of all TOFACITINIB adverse event reports.

Q: How dangerous is Dermatitis from TOFACITINIB?

Of 98 reports, 1 (1.0%) resulted in death and 38 required hospitalization.

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 98 reports of Dermatitis have been filed in association with TOFACITINIB (XELJANZ XR). This represents 0.1% of all adverse event reports for TOFACITINIB.

Reports of Dermatitis with TOFACITINIB

0.1%

of all TOFACITINIB reports

Deaths

Hospitalizations

How Dangerous Is Dermatitis From TOFACITINIB?

Of the 98 reports, 1 (1.0%) resulted in death, 38 (38.8%) required hospitalization, and 19 (19.4%) were considered life-threatening.

Is Dermatitis Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 98 reports have been filed with the FAERS database.

What Other Side Effects Does TOFACITINIB Cause?

Drug ineffective (30,382) Pain (21,659) Condition aggravated (16,925) Arthralgia (15,640) Fatigue (13,551) Rheumatoid arthritis (12,277) Off label use (11,736) Headache (11,061) Joint swelling (10,686) Malaise (9,040)

What Other Drugs Cause Dermatitis?

DUPILUMAB (3,823) ADAPALENE (2,088) AVOBENZONE\OCTISALATE\OCTOCRYLENE (1,615) ADALIMUMAB (530) METHOTREXATE (452) ETANERCEPT (317) SECUKINUMAB (294) INFLIXIMAB (268) NIVOLUMAB (251) DENOSUMAB (246)

Which TOFACITINIB Alternatives Have Lower Dermatitis Risk?

TOFACITINIB vs TOFERSEN TOFACITINIB vs TOLNAFTATE TOFACITINIB vs TOLODODEKIN ALFA TOFACITINIB vs TOLTERODINE TOFACITINIB vs TOLVAPTAN

TOFACITINIB Full Profile All Dermatitis Reports All Drugs Causing Dermatitis TOFACITINIB Demographics